Nicholas A. Zorko

Mar 20, 2024 | urotoday.com | Nicholas A. Zorko

Read the Full Video TranscriptAndrea Miyahira: Hi everyone, I'm Andrea Miyahira at the Prostate Cancer Foundation. With me is Dr. Nicholas Zorko, an assistant professor at the University of Minnesota. He will discuss the paper "Natural Killer Cell Infiltration in Prostate Cancers Predicts Improved Patient Outcomes" that his group recently published in Prostate Cancer and Prostatic Diseases. Dr. Zorko, thanks for joining us today.

Feb 27, 2024 | nature.com | Nicholas A. Zorko |Yousef Zakharia |Vivek Narayan |Elisabeth I. Heath |Allison Makovec

AbstractNatural killer (NK) cells are non-antigen specific innate immune cells that can be redirected to targets of interest using multiple strategies, although none are currently FDA-approved. We sought to evaluate NK cell infiltration into tumors to develop an improved understanding of which histologies may be most amenable to NK cell-based therapies currently in the developmental pipeline.

Apr 19, 2023 | mdpi.com | Emmanuel S. Antonarakis |Pedro Barata |Sree M. Lanka |Nicholas A. Zorko

Open AccessReviewby 1, 2, 2 and 3,* 1Deming Department of Medicine, Tulane University, New Orleans, LA 70112, USA2Department of Hematology and Oncology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA3Department of Hematology and Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA*Author to whom correspondence should be addressed. Curr. Oncol.